Smilkov, Emil Andonov
Grundtvig, Natalia
Tolnai, Daniel
Carlsen, Jonathan Frederik
Jensen, Rigmor Højland
Hansen, Martin Lundsgaard
Schytz, Henrik Winther
Funding for this research was provided by:
Novo Nordisk Fonden (NNF24OC0087919)
Article History
Received: 25 March 2025
Accepted: 20 November 2025
First Online: 2 December 2025
Change Date: 12 January 2026
Change Type: Update
Change Details: The original online version of this article was revised: license change to Open Access
Declarations
:
: The Neurological Department approved the study as a quality assurance study, and it was also approved by the Regional Ethics Committee. According to the Neurological Department, the Regional and National Ethics Committee, and Danish Law, patient consent is not necessary in a quality assurance study as the study collected information from patients undergoing usual treatment and evaluation. Furthermore, all data presented in this study were fully anonymized. The study was conducted in accordance with Danish Data Laws and the Helsinki Declaration.
: The authors declare no competing interests.